1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Mean values of FTB classes and normalized rCBV in histopathologically defined treatment effect and tumor groups^{^a}
TE Tumor P Values
FTB_low 54.8 (22.3) 33.1 (20.8) .002
FTB_mid 27.0 (15.4) 21.3 (11.3) .16
FTB_high 18.2 (14.4) 45.5 (22.6) <.001
rCBV 1.2 (0.6) 2.1 (1.0) <.001
↵a Values are reported as mean (SD), except for P values.
	TE	Tumor	P Values
FTB_low	54.8 (22.3)	33.1 (20.8)	.002
FTB_mid	27.0 (15.4)	21.3 (11.3)	.16
FTB_high	18.2 (14.4)	45.5 (22.6)	<.001
rCBV	1.2 (0.6)	2.1 (1.0)	<.001